Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model

Radiation Research

Volumn 165, Issue 3, 2006, Pages 326-336

  Ljungkvist, Anna S E ^a   Bussink, Johan ^a   Kaanders, Johannes H A M ^a   Wiedenmann, Nicole E ^b   Vlasman, Renske ^a   Van Der Kogel, Albert J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CASPASE 3; OXYGEN; PIMONIDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL DENSITY; CELL HYPOXIA; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE OXYGENATION; TUMOR BLOOD FLOW;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS;

ANIMALIA; MURINAE;

EID: 33644516583     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3515.1     Document Type: Article

References (70)

1. I. F. Tannock, The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br. J. Cancer 22, 258-273 (1968).
2. D. G. Hirst and J. Denekamp, Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet. 12, 31-42 (1979).
3. J. Bussink, J. H. A. M. Kaanders, P. F. J. W. Rijken, C. A. Martindale and A. J. van der Kogel, Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br. J. Cancer 77, 57-64 (1998).
4. A. S. E. Ljungkvist, J. Bussink, P. F. J. W. Rijken, J. H. A. M. Kaanders, A. J. van der Kogel and J. Denekamp, Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 54, 215-228 (2002).
5. R. H. Thomlinson and L. H. Gray, The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer IX, 539-549 (1955).
6. P. Vaupel, F. Kallinowski and P. Okunieff, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res. 49, 6449-6465 (1989).
7. K. I. E. M. Wijffels, J. H. A. M. Kaanders, P. F. J. W. Rijken, J. Bussink, F. J. van den Hoogen, H. A. M. Marres, P. C. M. de Wilde, J. A. Raleigh and A. J. van der Kogel, Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. Br. J. Cancer 83, 674-683 (2000).
8. E. M. Zeman, D. P. Calkins, J. M. Cline, D. E. Thrall and J. A. Raleigh, The relationship between proliferative and oxygenation status in spontaneous canine tumors. Int. J. Radiat. Oncol. Biol. Phys. 27, 891-898 (1993).
9. M. W. Dewhirst, H. Kimura, S. W. Rehmus, R. D. Braun, D. Papahadjopoulos, K. Hong and T. W. Secomb, Microvascular studies on the origins of perfusion-limited hypoxia. Br. J. Cancer 27 (Suppl.), S247-S251 (1996).
10. K. H. Pigott, S. A. Hill, D. J. Chaplin and M. I. Saunders, Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiother. Oncol. 40, 45-50 (1996).
11. M. Höckel and P. Vaupel, Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93, 266-276 (2001).
12. E. K. Rofstad, Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 76, 589-605 (2000).
13. M. B. Barton, T. J. Keane, T. Gadalla and E. Maki, The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother. Oncol. 23, 137-143 (1992).
14. A. Fyles, T. J. Keane, M. Barton and J. Simm, The effect of treatment duration in the local control of cervix cancer. Radiother. Oncol. 25, 273-279 (1992).
15. W. R. Lee, R. B. Marcus, Jr., M. D. Sombeck, W. M. Mendenhall, L. S. Morgan, D. E. Freeman and R. R. Million, Radiotherapy alone for carcinoma of the vagina: The importance of overall treatment time. Int. J. Radiat. Oncol. Biol. Phys. 29, 983-988 (1994).
16. H. R. Withers, J. M. Taylor and B. Maciejewski, The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27, 131-146 (1988).
17. J. M. Taylor, H. R. Withers and W. M. Mendenhall, Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother. Oncol. 17, 95-102 (1990).
18. M. Saunders, S. Dische, A. Barrett, A. Harvey, D. Gibson and M. Parmar, Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial. CHART Steering Committee. Lancet 350, 161-165 (1997).
19. J. Overgaard, H. S. Hansen, L. Specht, M. Overgaard, C. Grau, E. Andersen, J. Bentzen, L. Bastholt, O. Hansen and J. F. Evensen, Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362, 933-940 (2003).
20. K. K. Fu, T. F. Pajak, A. Trotti, C. U. Jones, S. A. Spencer, T. L. Phillips, A. S. Garden, J. A. Ridge and K. K. Ang, A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 48, 7-16 (2000).
21. G. D. Wilson, S. Dische and M. I. Saunders, Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 36, 189-197 (1995).
22. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher and M. W. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38, 285-289 (1997).
23. A. Fyles, M. Milosevic, D. Hedley, M. Pintilie, W. Levin, L. Manchul and R. P. Hill, Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J. Clin. Oncol. 20, 680-687 (2002).
24. M. Höckel, K. Schlenger, B. Aral, M. Mitze, U. Schaffer and P. Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56, 4509-4515 (1996).
25. J. H. A. M. Kaanders, K. I. E. M. Wijffels, H. A. M. Marres, A. S. E. Ljungkvist, L. A. M. Pop, F. J. A. van den Hoogen, P. C. M. de Wilde, J. Bussink, J. A. Raleigh and A. J. van der Kogel, Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 62, 7066-7074 (2002).
26. R. F. Kallman, The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology 105, 135-142 (1972).
27. J. Bussink, J. H. A. M. Kaanders, P. F. J. W. Rijken, J. A. Raleigh and A. J. van der Kogel, Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line. Radiat. Res. 153, 398-404 (2000).
28. P. L. Olive, Radiation-induced reoxygenation in the SCCVII murine tumour: Evidence for a decrease in oxygen consumption and an increase in tumour perfusion. Radiother. Oncol. 32, 37-46 (1994).
29. R. Murata, Y. Shibamoto, K. Sasai, N. Oya, T. Shibata, T. Takagi and M. Abe, Reoxygenation after single irradiation in rodent tumors of different types and sizes. Int. J. Radiat. Oncol. Biol. Phys. 34, 859-865 (1996).
30. M. J. Dorie and R. F. Kallman, Reoxygenation in the RIF-1 tumor. Int. J. Radiat. Oncol. Biol. Phys. 10, 687-693 (1984).
31. N. Crokart, B. F. Jordan, C. Baudelet, R. Ansiaux, O. Sonveuax, V. Gregoire, N. Begheon, J. d. Wever, C. Bouzin and B. Gallez, Early reoxygenation in tumors after irradiation: Determining factors and consequences for radiotherapy regimens using daily multiple fractions. Int. J. Radiat. Oncol. Biol. Phys. 63, 901-910 (2005).
32. A. S. Kennedy, J. A. Raleigh, G. M. Perez, D. P. Calkins, D. E. Thrall, D. B. Novotny and M. A. Varia, Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays. Int. J. Radiat. Oncol. Biol. Phys. 37, 897-905 (1997).
33. B. M. Fenton, S. F. Paoni, B. K. Beauchamp and I. Ding, Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis. Br. J. Cancer 86, 1831-1836 (2002).
34. I. J. Hoogsteen, H. A. M. Marres, K. I. E. M. Wijffels, P. F. J. W. Rijken, J. P. W. Peters, F. J. van den Hoogen, E. Oosterwijk, A. J. van der Kogel and J. H. A. M. Kaanders, Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin. Cancer Res. 11, 97-106 (2005).
35. S. M. Evans, S. Hahn, D. R. Pook, W. T. Jenkins, A. A. Chalian, P. Zhang, C. Stevens, R. Weber, G. Weinstein and C. J. Koch, Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 60, 2018-2024 (2000).
36. A. S. E. Ljungkvist, J. Bussink, P. F. J. W. Rijken, J. A. Raleigh, J. Denekamp and A. J. van der Kogel, Changes in tumor hypoxia measured with a double hypoxic marker technique. Int. J. Radiat. Oncol. Biol. Phys. 48, 1529-1538 (2000).
37. A. S. E. Ljungkvist, J. Bussink, P. F. J. W. Rijken, J. A. Raleigh, J. H. A. M. Kaanders and A. J. van der Kogel, Hypoxic cell turnover in different solid lines. Int. J. Radiat. Oncol. Biol. Phys. 62, 1157-1168 (2005).
38. H. W. M. van Laarhoven, J. Bussink, J. Lok, C. J. A. Punt, A. Heerschap and A. J. van der Kogel, Effects of nicotinamide and carbogen in different murine colon carcinomas: Immunohistochemical analysis of vascular architecture and microenvironmental parameters. Int. J. Radiat. Oncol. Biol. Phys. 60, 310-321 (2004).
39. C. D. Wilson, N. J. McNally, S. Dische, M. I. Saunders, C. Des Rochers, A. A. Lewis and M. H. Bennett, Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br. J. Cancer 58, 423-431 (1988).
40. K. I. E. M. Wijffels, J. H. A. M. Kaanders, H. A. M. Marres, J. Bussink, H. P. W. Peters, P. F. J. W. Rijken, P. C. M. de Wilde and A. J. van der Kogel, Patterns of proliferation related to vasculature in human head-and-neck carcinomas before and after transplantation in nude mice. Int. J. Radiat Oncol. Biol. Phys. 51, 1346-1353 (2001).
41. G. J. Peters, J. Van Dijk, J. C. Nadal, C. J. Van Groeningen, J. Lankelma and H. M. Pinedo, Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In Vivo 1, 113-117 (1987).
42. J. A. Raleigh, A. J. Franko, E. O. Treiber, J. A. Lunt and P. S. Allen, Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice: Detection by F-19 nuclear magnetic resonance at 2.35 T. Int. J. Radiat. Oncol. Biol. Phys. 12, 1243-1245 (1986).
43. C. Azuma, J. A. Raleigh and D. E. Thrall, Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiat. Res. 148, 35-42 (1997).
44. G. E. Arteel, R. G. Thurman, J. M. Yates and J. A. Raleigh, Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer 72, 889-895 (1995).
45. J. A. Raleigh, G. G. Miller, A. J. Franko, C. J. Koch, A. F. Fuciarelli and D. A. Kelly, Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer 56, 395-400 (1987).
46. P. F. J. W. Rijken, J. P. W. Peters and A. J. van der Kogel, Quantitative analysis of varying hypoxic profiles in relation to functional vessels in different human glioma xenograft lines. Radiat. Res. 157, 626-632 (2002).
47. P. F. J. W. Rijken, H. J. J. A. Bernsen, J. P. W. Peters, R. J. Hodgkiss, J. A. Raleigh and A. J. van der Kogel, Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: A quantitative multi-parameter analysis. Int. J. Radiat. Oncol. Biol. Phys. 48, 571-582 (2000).
48. J. A. Raleigh, S. C. Chou, G. E. Arteel and M. R. Horsman, Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res. 151, 580-589 (1999).
49. I. H. Kim and J. M. Brown, Reoxygenation and rehypoxiation in the SCCVII mouse tumor. Int. J. Radiat. Oncol. Biol. Phys. 29, 493-497 (1994).
50. R. E. Durand and E. Sham, The lifetime of hypoxic human tumor cells. Int. J. Radiat. Oncol. Biol. Phys. 42, 711-715 (1998).
51. J. A. Raleigh, A. J. Franko, C. J. Koch and J. L. Born, Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: Evidence that a side-chain label is bound as efficiently as a ring label. Br. J. Cancer 51, 229-235 (1985).
52. A. J. Varghese, Glutathione conjugates of misonidazole. Biochem. Biophys. Res. Commun. 112, 1013-1020 (1983).
53. E. Chacon, C. J. Morrow, A. A. Leon, J. L. Born and B. R. Smith, Regioselective formation of a misonidazole-glutathione conjugate as a function of pH during chemical reduction. Biochem. Pharmacol. 37, 361-363 (1988).
54. J. A. Raleigh and C. J. Koch, Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharmacol. 40, 2457-2464 (1990).
55. K. L. Bennewith and R. E. Durand, Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Res. 64, 6183-6189 (2004).
56. J. D. Chapman, A. J. Franko and J. Sharplin, A marker for hypoxic cells in tumours with potential clinical applicability. Br. J. Cancer 43, 546-550 (1981).
57. M. W. Gross, U. Karbach, K. Groebe, A. J. Franko and W. Mueller Klieser, Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int. J. Cancer 61, 567-573 (1995).
58. D. E. Thrall, M. C. McEntee, J. M. Cline and J. A. Raleigh, ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation. Int. J. Radiat. Oncol. Biol. Phys. 28, 649-659 (1994).
59. B. M. Fenton, E. M. Lord and S. F. Paoni, Effects of radiation on tumor intravascular oxygenation, vascular configuration, development of hypoxia, and clonogenic survival. Radiat. Res. 155, 360-368 (2001).
60. M. J. Dorie and R. F. Kallman, Reoxygenation of the RIF-1 tumor after fractionated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 12, 1853-1859 (1986).
61. S. Walenta and W. Mueller Klieser, Oxygen consumption rate of tumour cells as a function of their proliferative status. Adv. Exp. Med. Biol. 215, 389-391 (1987).
62. 2-phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. Radiat. Res. 146, 139-143 (1996).
63. 2 blocks, cyclin B expression and cdc2 expression in human squamous carcinoma cell lines with different radiosensitivities. Radiother. Oncol. 33, 217-227 (1994).
64. L. Zamai, E. Falcieri, P. Gobbi, S. Santi, M. Falconi, G. Marhefka and M. Vitale, Anti-BrdUrd labeling of newly synthesized DNA in HL-60 cells triggered to apoptosis. Cytometry 25, 324-332 (1996).
65. A. H. Kyle, L. A. Huxham, J. H. Baker, H. E. Burston and A. I. Minchinton, Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent. Cancer Res. 63, 5707-5711 (2003).
66. M. H. Bennett, G. D. Wilson, S. Dische, M. I. Saunders, C. A. Martindale, B. M. Robinson, A. E. O'Halloran, M. D. Leslie and J. H. Laing, Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer 65, 870-878 (1992).
67. H. L. Janssen, A. S. Ljungkvist, P. F. Rijken, D. Sprang, J. Bussink, A. J. van der Kogel, K. M. Haustermans and A. C. Begg, Thymidine analogues to assess microperfusion in human tumors. Int. J. Radiat. Oncol. Biol. Phys. 62, 1169-1175 (2005).
68. T. W. Secomb, R. Hsu, E. T. Ong, J. F. Gross and M. W. Dewhirst, Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol. 34, 313-316 (1995).
69. D. M. Brizel, S. P. Scully, J. M. Harrelson, L. J. Layfield, R. K. Dodge, H. C. Charles, T. V. Samulski, L. R. Prosnitz and M. W. Dewhirst, Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 56, 5347-5350 (1996).
70. 2) during accelerated radiotherapy of head and neck carcinoma. Eur. J. Cancer 34, 856-861 (1998).